SAN FRANCISCO--(BUSINESS WIRE)--Cappella Medical Devices Ltd (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, announced today at the 2011 TCT (Transcatheter Cardiovascular Therapeutics) Conference in San Francisco results from several long term studies of its Sideguard® technology. These studies document the need to treat coronary bifurcation disease with a dedicated sidebranch system versus the traditional provisional approach.
